Dechert Advises on Series B Investments in Stilla Technologies
February 14, 2020
February 14, 2020
PHILADELPHIA, Pennsylvania, Feb. 14 -- Dechert, a law firm, issued the following news:
Dechert advised Tuspark Capital Management, Illumina Ventures, Kurma Partners, Idinvest, LBO France, BNP Paribas Developpement and Paris Saclay Seed Fund in connection with their Series B investment in Stilla Technologies, a company that develops, manufactures and sells equipment for the analysis of nucleic acids by digital PCR, for a total amount of Euros 20 million.
The Dechert team . . .
Dechert advised Tuspark Capital Management, Illumina Ventures, Kurma Partners, Idinvest, LBO France, BNP Paribas Developpement and Paris Saclay Seed Fund in connection with their Series B investment in Stilla Technologies, a company that develops, manufactures and sells equipment for the analysis of nucleic acids by digital PCR, for a total amount of Euros 20 million.
The Dechert team . . .